Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma Psychopathology
Status: | Active, not recruiting |
---|---|
Conditions: | Anxiety, Anxiety, Depression |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/16/2018 |
Start Date: | July 13, 2015 |
End Date: | May 2019 |
This randomized controlled trial uses a modularized cognitive behavioral resilience training
(MCBRT) intervention to probe risk and resilience mechanisms linked to post-trauma
psychopathology. Ninety participants with a history of interpersonal trauma during childhood
or adolescence and mild to moderate distress will be randomized to MCBRT or a health
education control condition. The primary aims of this proposal are to examine whether
individuals who receive MCBRT demonstrate increases in psychological resilience, biological
resilience, and extinction learning compared to those in the control group. This study will
also explore associations between these psychobiobehavioral risk and resilience factors.
(MCBRT) intervention to probe risk and resilience mechanisms linked to post-trauma
psychopathology. Ninety participants with a history of interpersonal trauma during childhood
or adolescence and mild to moderate distress will be randomized to MCBRT or a health
education control condition. The primary aims of this proposal are to examine whether
individuals who receive MCBRT demonstrate increases in psychological resilience, biological
resilience, and extinction learning compared to those in the control group. This study will
also explore associations between these psychobiobehavioral risk and resilience factors.
Inclusion Criteria:
1. 18 years of age or older
2. fluent in English
3. history of childhood interpersonal trauma (e.g., sexual assault, physical assault,
witnessing assault before age 18)
4. mild to moderate distress indicated by a score of 10-20 on the depression scale, 8-14
on the anxiety scale, or 15-25 on the stress scale of the DASS-21.
Exclusion Criteria:
1. severe distress indicated by a score >20 on the depression scale, >14 on the anxiety
scale, or >25 on the stress scale of the DASS-21
2. DSM-5 criterion A trauma in the past month
3. color blindness based on self-report (because of inability to complete the fear
conditioning task)
4. auditory impairment based on audiometer screening (because of inability to complete
the fear conditioning task)
5. lifetime psychotic or bipolar disorder
6. substance abuse or dependence within past 6 months
7. concurrent psychotherapy initiated within 3 months of randomization
8. ongoing psychotherapy of any duration directed toward treatment of trauma-related
psychopathology (e.g., CBT)
9. must be on a stable dose of psychotropic or adrenergically-active medications (e.g.,
beta blockers) for at least 6 weeks prior to eligibility screening
10. mental retardation or significant cognitive impairment
11. serious medical illness or instability for which hospitalization may be likely within
the next year
12. significant suicidal ideation indicated by "yes" on Columbia Suicide Severity Rating
Scale item 4 (active suicidal ideation with some intent to act) or enacted suicidal
behaviors within 6 months prior to eligibility
13. current legal actions related to trauma.
We found this trial at
1
site
1653 W. Congress Parkway
Chicago, Illinois 60612
Chicago, Illinois 60612
(312) 942-5000
Phone: 312-563-6645
Rush University Medical Center Rush University Medical Center encompasses a 664-bed hospital serving adults and...
Click here to add this to my saved trials